首页 > 最新文献

Clinical nutrition最新文献

英文 中文
Letter to the Editor–The genetically predicted causal associations between circulating 3-hydroxybutyrate levels and malignant neoplasms: A pan-cancer Mendelian randomization study 致编辑的信——循环3-羟基丁酸水平与恶性肿瘤之间的遗传预测因果关系:一项泛癌症孟德尔随机研究。
IF 6.6 2区 医学 Q1 NUTRITION & DIETETICS Pub Date : 2025-01-01 DOI: 10.1016/j.clnu.2024.12.005
Qing Zhou
{"title":"Letter to the Editor–The genetically predicted causal associations between circulating 3-hydroxybutyrate levels and malignant neoplasms: A pan-cancer Mendelian randomization study","authors":"Qing Zhou","doi":"10.1016/j.clnu.2024.12.005","DOIUrl":"10.1016/j.clnu.2024.12.005","url":null,"abstract":"","PeriodicalId":10517,"journal":{"name":"Clinical nutrition","volume":"44 ","pages":"Pages 122-123"},"PeriodicalIF":6.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142812351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the editor: Effectiveness of whey protein supplementation on muscle strength and physical performance of older adults: A systematic review and meta-analysis of randomized clinical trials 给编辑的信:补充乳清蛋白对老年人肌肉力量和身体表现的有效性:随机临床试验的系统回顾和荟萃分析。
IF 6.6 2区 医学 Q1 NUTRITION & DIETETICS Pub Date : 2025-01-01 DOI: 10.1016/j.clnu.2024.12.006
Wensi Ouyang, Guimei Guo
{"title":"Letter to the editor: Effectiveness of whey protein supplementation on muscle strength and physical performance of older adults: A systematic review and meta-analysis of randomized clinical trials","authors":"Wensi Ouyang, Guimei Guo","doi":"10.1016/j.clnu.2024.12.006","DOIUrl":"10.1016/j.clnu.2024.12.006","url":null,"abstract":"","PeriodicalId":10517,"journal":{"name":"Clinical nutrition","volume":"44 ","pages":"Pages 132-133"},"PeriodicalIF":6.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142817436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhancing metabolic and inflammatory status in insulin-resistant rats: Acute intervention with cocoa flavanols and submaximal aerobic exercise activates intracellular signaling pathways for glucose metabolism 改善胰岛素抵抗大鼠的代谢和炎症状态:可可黄烷醇和亚极限有氧运动的急性干预可激活葡萄糖代谢的细胞内信号通路。
IF 6.6 2区 医学 Q1 NUTRITION & DIETETICS Pub Date : 2025-01-01 DOI: 10.1016/j.clnu.2024.11.043
B.P. Melo , A.C. Zacarias , J.C.C. Oliveira , L.M. de Souza Cordeiro , N.A.C. Horta , M.O. Poletini , C. Tonoli , M.L. Dos Santos , S.P. Wanner , R. Meeusen , E. Heyman , G.F. Avelar , D.D. Soares

Introduction

Type 2 diabetes, characterized by hyperglycemia, is closely linked to obesity and low-grade inflammation. Acute cocoa flavanols (CF) intake has demonstrated benefits in vasoreactivity, cognitive functions, and antioxidant enzyme activity. However, the physiological mechanisms of CF concerning glucose uptake, inflammatory mediators, and their interplay with aerobic exercise remain unclear in populations with metabolic diseases.

Objective

This study aims to investigate the acute effects of CF, alone or combined with acute aerobic exercise on mechanisms involved in glucose uptake and inflammatory mediators in the liver, skeletal muscle, pancreas, and adipose tissue in insulin-resistant (IR) rats.

Methods

Sixty-four Wistar rats (250 ± 10g; 15 weeks age) were subjected to a regular chow (CON) or an obesity-associated insulin-resistant (IR) state induced by a high-fat diet and fructose-rich beverage for 30 days. Seventy-two hours after an incremental maximal treadmill running test, rats received a placebo solution or CF supplementation (45 mg·kg-1 of body weight). One hour later, they either rested or ran on a treadmill at 60 % of peak oxygen uptake (VO2peak) for 30 min. Euthanasia occurred 30 min post-experimental sessions. Inflammatory and anti-inflammatory cytokines were assayed using ELISA in the liver, pancreas, gastrocnemius muscle, and epididymal adipose tissues. TRB3 and CPT1 mRNA were assessed by q-RTPCR in the liver and gastrocnemius muscle while Akt and AMPK phosphorylation were examined by immunohistochemistry.

Results

CF attenuated hyperglycemia observed after submaximal aerobic exercise in IR rats (p < 0.001). In the liver, CF exhibited additive effects to aerobic exercise, enhancing Akt protein phosphorylation, potentially contributing to improved glucose uptake in IR rats. Submaximal aerobic exercise and CF increased AMPK protein phosphorylation in the liver (p < 0.001) and skeletal muscle (p < 0.001), reduced TRB3 gene expression (p < 0.01), elevated CPT-1a gene expression (p < 0.001), and ameliorated the inflammatory milieu in the pancreas, adipose tissue, liver, and gastrocnemius muscle.

Conclusion

Acute intake, of CF combined with submaximal aerobic exercise activates key proteins and genes involved in glucose uptake and lipid metabolism, improving the inflammatory milieu. This synergistic effect may contribute to mitigating metabolic complications associated with insulin resistance.
引言:以高血糖为特征的 2 型糖尿病与肥胖和低度炎症密切相关:以高血糖为特征的 2 型糖尿病与肥胖和低度炎症密切相关。急性可可黄烷醇(CF)摄入对血管活性、认知功能和抗氧化酶活性有好处。然而,在患有代谢性疾病的人群中,可可黄烷醇在葡萄糖摄取、炎症介质方面的生理机制及其与有氧运动的相互作用仍不清楚:本研究旨在探讨 CF 单独或与急性有氧运动相结合对胰岛素抵抗(IR)大鼠肝脏、骨骼肌、胰腺和脂肪组织中葡萄糖摄取和炎症介质相关机制的急性影响:将 64 只 Wistar 大鼠(250 ± 10 克;15 周龄)置于普通饲料(CON)或由高脂肪饮食和富含果糖的饮料诱导的肥胖相关胰岛素抵抗(IR)状态下 30 天。在进行增量最大跑步机跑步测试 72 小时后,大鼠接受安慰剂溶液或 CF 补充剂(45 毫克-公斤-1 体重)。一小时后,大鼠要么休息,要么以峰值摄氧量(VO2peak)的 60% 在跑步机上跑步 30 分钟。实验结束后30分钟安乐死。在肝脏、胰腺、腓肠肌和附睾脂肪组织中使用酶联免疫吸附法测定炎症和抗炎细胞因子。肝脏和腓肠肌中的 TRB3 和 CPT1 mRNA 通过 q-RTPCR 进行评估,Akt 和 AMPK 磷酸化通过免疫组化进行检测:结果:CF可减轻IR大鼠亚极限有氧运动后的高血糖症状(p 结论:CF可减轻IR大鼠亚极限有氧运动后的高血糖症状:急性摄入 CF 并进行亚极限有氧运动可激活参与葡萄糖摄取和脂质代谢的关键蛋白和基因,改善炎症环境。这种协同效应可能有助于减轻与胰岛素抵抗有关的代谢并发症。
{"title":"Enhancing metabolic and inflammatory status in insulin-resistant rats: Acute intervention with cocoa flavanols and submaximal aerobic exercise activates intracellular signaling pathways for glucose metabolism","authors":"B.P. Melo ,&nbsp;A.C. Zacarias ,&nbsp;J.C.C. Oliveira ,&nbsp;L.M. de Souza Cordeiro ,&nbsp;N.A.C. Horta ,&nbsp;M.O. Poletini ,&nbsp;C. Tonoli ,&nbsp;M.L. Dos Santos ,&nbsp;S.P. Wanner ,&nbsp;R. Meeusen ,&nbsp;E. Heyman ,&nbsp;G.F. Avelar ,&nbsp;D.D. Soares","doi":"10.1016/j.clnu.2024.11.043","DOIUrl":"10.1016/j.clnu.2024.11.043","url":null,"abstract":"<div><h3>Introduction</h3><div>Type 2 diabetes, characterized by hyperglycemia, is closely linked to obesity and low-grade inflammation. Acute cocoa flavanols (CF) intake has demonstrated benefits in vasoreactivity, cognitive functions, and antioxidant enzyme activity. However, the physiological mechanisms of CF concerning glucose uptake, inflammatory mediators, and their interplay with aerobic exercise remain unclear in populations with metabolic diseases.</div></div><div><h3>Objective</h3><div>This study aims to investigate the acute effects of CF, alone or combined with acute aerobic exercise on mechanisms involved in glucose uptake and inflammatory mediators in the liver, skeletal muscle, pancreas, and adipose tissue in insulin-resistant (IR) rats.</div></div><div><h3>Methods</h3><div>Sixty-four Wistar rats (250 ± 10g; 15 weeks age) were subjected to a regular chow (CON) or an obesity-associated insulin-resistant (IR) state induced by a high-fat diet and fructose-rich beverage for 30 days. Seventy-two hours after an incremental maximal treadmill running test, rats received a placebo solution or CF supplementation (45 mg·kg<sup>-1</sup> of body weight). One hour later, they either rested or ran on a treadmill at 60 % of peak oxygen uptake (VO<sub>2peak</sub>) for 30 min. Euthanasia occurred 30 min post-experimental sessions. Inflammatory and anti-inflammatory cytokines were assayed using ELISA in the liver, pancreas, gastrocnemius muscle, and epididymal adipose tissues. TRB3 and CPT1 mRNA were assessed by q-RTPCR in the liver and gastrocnemius muscle while Akt and AMPK phosphorylation were examined by immunohistochemistry.</div></div><div><h3>Results</h3><div>CF attenuated hyperglycemia observed after submaximal aerobic exercise in IR rats (p &lt; 0.001). In the liver, CF exhibited additive effects to aerobic exercise, enhancing Akt protein phosphorylation, potentially contributing to improved glucose uptake in IR rats. Submaximal aerobic exercise and CF increased AMPK protein phosphorylation in the liver (p &lt; 0.001) and skeletal muscle (p &lt; 0.001), reduced TRB3 gene expression (p &lt; 0.01), elevated CPT-1a gene expression (p &lt; 0.001), and ameliorated the inflammatory milieu in the pancreas, adipose tissue, liver, and gastrocnemius muscle.</div></div><div><h3>Conclusion</h3><div>Acute intake, of CF combined with submaximal aerobic exercise activates key proteins and genes involved in glucose uptake and lipid metabolism, improving the inflammatory milieu. This synergistic effect may contribute to mitigating metabolic complications associated with insulin resistance.</div></div>","PeriodicalId":10517,"journal":{"name":"Clinical nutrition","volume":"44 ","pages":"Pages 166-177"},"PeriodicalIF":6.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142827615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nutritional interventions in randomised clinical trials for people with incurable solid cancer: A systematic review 对无法治愈的实体癌患者的随机临床试验中的营养干预:一项系统综述。
IF 6.6 2区 医学 Q1 NUTRITION & DIETETICS Pub Date : 2025-01-01 DOI: 10.1016/j.clnu.2024.12.008
Amy Mcluskie , Megan Bowers , Jo Bayly , Michael S. Yule , Matthew Maddocks , Marie Fallon , Richard JE. Skipworth , Barry J.A. Laird
<div><h3>Background & aims</h3><div>Malnutrition is highly prevalent in those with cancer and more so in those with incurable cancer. In incurable cancer, it is widely agreed that optimal nutritional care has the potential to positively impact patient and caregiver distress and oncological outcomes. The aim of this systematic review was to describe the diversity and frequency of nutritional interventions, whether given in isolation or as part of a multimodal intervention in those with incurable cancer, in randomised controlled trials. The secondary aims were to describe adherence and their efficacy.</div></div><div><h3>Methods</h3><div>This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines. The following databases were searched electronically: Medical Literature Analysis and Retrieval System Online (MEDLINE), Excerpta Medica database (EMBASE), Cumulated Index to Nursing and Allied Health Literature (CINAHL) and Cochrane Central Register of Controlled Trials (CENTRAL) with the time frame from January 2000 to 7th September 2023. Eligible studies included adult patients (≥18 years) diagnosed with incurable solid cancer with a sample size ≥40. Studies were to be primary research and delivered for at least 14 days to allow for efficacy. They were to include a nutritional intervention encompassing at least one of the following: dietary counselling, oral nutritional supplements (ONS), enteral tube feeding and/or parenteral nutrition (PN), given in isolation or as part of a multi-modal intervention. Studies were excluded if the population contained patients who had completed curative treatment or are being treated with curative intent, haematological cancers, or if they examined the effects of micronutrients, proteins, amino acids or fatty acids given in isolation. The quality of the included studies was assessed using the Cochrane risk of bias tool for randomised trials (RoB2). A balloon plot was produced to present the results in addition to a table with a narrative summary of the primary outcomes.</div></div><div><h3>Results</h3><div>A total of 7968 studies were identified, of which 18 met the eligibility criteria. This included 2720 study participants. The included studies comprised: multimodal interventions (n = 7), dietary counselling (n = 2), nutritional supplementation with or without dietary counselling (n = 7) and PN (n = 2). Primary outcomes included quality of life (QoL), body composition and nutritional status. For QoL, this was reported in 15 studies, 4 studies showed a significant improvement. Body composition was evaluated in 15 studies, 5 of which showed a significant improvement in body weight and two in fat-free mass (FFM). Nutritional status was reported in 6 studies with one showing a significant difference in Patient-Generated Subjective Global Assessment (PG-SGA) score. The risk of bias was deemed ‘low’ in 6 studies, with ‘some concerns’
背景与目的:营养不良在癌症患者中非常普遍,在无法治愈的癌症患者中更是如此。在无法治愈的癌症中,人们普遍认为,最佳的营养护理有可能对患者和护理人员的痛苦和肿瘤结果产生积极影响。本系统综述的目的是描述随机对照试验中营养干预的多样性和频率,无论是单独给予还是作为多模式干预的一部分,用于治疗无法治愈的癌症。次要目的是描述依从性及其疗效。方法:本系统评价按照系统评价和荟萃分析的首选报告项目(PRISMA)指南进行。以电子方式检索以下数据库:医学文献分析与检索系统在线(MEDLINE)、医学摘录数据库(EMBASE)、护理与相关健康文献累积索引(CINAHL)和Cochrane中央对照试验注册库(Central),检索时间范围为2000年1月至2023年9月7日。符合条件的研究包括诊断为无法治愈的实体癌的成年患者(≥18岁),样本量≥40。这些研究是初步研究,并且至少持续14天以达到疗效。它们将包括至少包括以下一项的营养干预:饮食咨询、口服营养补充剂(ONS)、肠内管喂养和/或肠外营养(PN),单独给予或作为多模式干预的一部分。如果研究人群中包含已完成治愈性治疗或正以治愈为目的接受治疗的患者、血液学癌症患者,或者研究人员检查了单独给予的微量营养素、蛋白质、氨基酸或脂肪酸的影响,则排除研究。使用Cochrane随机试验偏倚风险工具(RoB2)评估纳入研究的质量。除了主要结果的叙述性摘要表外,还制作了一个气球图来展示结果。结果:共纳入7968项研究,其中18项符合入选标准。这包括2720名研究参与者。纳入的研究包括:多模式干预(n = 7)、饮食咨询(n = 2)、有或没有饮食咨询的营养补充(n = 7)和PN (n = 2)。主要结局包括生活质量(QoL)、身体组成和营养状况。对于生活质量,15项研究报告了这一点,4项研究显示显着改善。在15项研究中评估了身体成分,其中5项研究显示体重有显著改善,2项研究显示无脂质量(FFM)有显著改善。6项研究报告了营养状况,其中一项研究显示患者主观整体评估(PG-SGA)评分存在显著差异。6项研究认为偏倚风险为“低”,10项研究认为偏倚风险为“一些担忧”,2项研究认为偏倚风险为“高风险”。研究之间存在异质性。结论:本系统综述强调了在生活质量、体重和营养摄入方面的一些积极发现。最佳营养干预尚未确定。未来的研究应在诊断时评估早期营养干预的有效性,包括定期检查及其对营养结局、生活质量和总生存期(OS)的影响。
{"title":"Nutritional interventions in randomised clinical trials for people with incurable solid cancer: A systematic review","authors":"Amy Mcluskie ,&nbsp;Megan Bowers ,&nbsp;Jo Bayly ,&nbsp;Michael S. Yule ,&nbsp;Matthew Maddocks ,&nbsp;Marie Fallon ,&nbsp;Richard JE. Skipworth ,&nbsp;Barry J.A. Laird","doi":"10.1016/j.clnu.2024.12.008","DOIUrl":"10.1016/j.clnu.2024.12.008","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Background &amp; aims&lt;/h3&gt;&lt;div&gt;Malnutrition is highly prevalent in those with cancer and more so in those with incurable cancer. In incurable cancer, it is widely agreed that optimal nutritional care has the potential to positively impact patient and caregiver distress and oncological outcomes. The aim of this systematic review was to describe the diversity and frequency of nutritional interventions, whether given in isolation or as part of a multimodal intervention in those with incurable cancer, in randomised controlled trials. The secondary aims were to describe adherence and their efficacy.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines. The following databases were searched electronically: Medical Literature Analysis and Retrieval System Online (MEDLINE), Excerpta Medica database (EMBASE), Cumulated Index to Nursing and Allied Health Literature (CINAHL) and Cochrane Central Register of Controlled Trials (CENTRAL) with the time frame from January 2000 to 7th September 2023. Eligible studies included adult patients (≥18 years) diagnosed with incurable solid cancer with a sample size ≥40. Studies were to be primary research and delivered for at least 14 days to allow for efficacy. They were to include a nutritional intervention encompassing at least one of the following: dietary counselling, oral nutritional supplements (ONS), enteral tube feeding and/or parenteral nutrition (PN), given in isolation or as part of a multi-modal intervention. Studies were excluded if the population contained patients who had completed curative treatment or are being treated with curative intent, haematological cancers, or if they examined the effects of micronutrients, proteins, amino acids or fatty acids given in isolation. The quality of the included studies was assessed using the Cochrane risk of bias tool for randomised trials (RoB2). A balloon plot was produced to present the results in addition to a table with a narrative summary of the primary outcomes.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;A total of 7968 studies were identified, of which 18 met the eligibility criteria. This included 2720 study participants. The included studies comprised: multimodal interventions (n = 7), dietary counselling (n = 2), nutritional supplementation with or without dietary counselling (n = 7) and PN (n = 2). Primary outcomes included quality of life (QoL), body composition and nutritional status. For QoL, this was reported in 15 studies, 4 studies showed a significant improvement. Body composition was evaluated in 15 studies, 5 of which showed a significant improvement in body weight and two in fat-free mass (FFM). Nutritional status was reported in 6 studies with one showing a significant difference in Patient-Generated Subjective Global Assessment (PG-SGA) score. The risk of bias was deemed ‘low’ in 6 studies, with ‘some concerns’","PeriodicalId":10517,"journal":{"name":"Clinical nutrition","volume":"44 ","pages":"Pages 201-219"},"PeriodicalIF":6.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142871649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond fat: Does semaglutide affect lean mass? 除了脂肪:西马鲁肽会影响瘦质量吗?
IF 6.6 2区 医学 Q1 NUTRITION & DIETETICS Pub Date : 2025-01-01 DOI: 10.1016/j.clnu.2024.12.004
Tannaz Jamialahmadi , Ali H. Eid , Kishore M. Gadde , Wael Almahmeed , Matthew Kroh , Mohammad Al Zein , Amirhossein Sahebkar
This opinion paper aims to discuss the influence of semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1RA), on lean mass beyond its impact on weight loss. Although significant weight loss is achieved with semaglutide, the impact of this drug on lean mass remains controversial. Several investigations have demonstrated that semaglutide-induced weight loss is linked to decreases in lean mass as well as fat mass; on the other hand, the ratio of lean mass to total body mass rises. Nevertheless, larger clinical trials have reported converse findings and significant reductions in lean mass following treatment with semaglutide. This disparity in research findings emphasizes the necessity for additional studies on this subject because semaglutide use is rising quickly.
本文旨在探讨胰高血糖素样肽-1受体激动剂(GLP-1RA) semaglutide在减肥作用之外对瘦体重的影响。尽管使用西马鲁肽可以显著减轻体重,但这种药物对瘦体重的影响仍然存在争议。几项调查表明,西马柳肽引起的体重减轻与瘦体重和脂肪量的减少有关;另一方面,瘦体重占总体重的比例上升。然而,更大规模的临床试验报告了相反的结果,使用西马鲁肽治疗后瘦体重显著减少。研究结果的这种差异强调了对这一主题进行进一步研究的必要性,因为semaglutide的使用正在迅速增加。
{"title":"Beyond fat: Does semaglutide affect lean mass?","authors":"Tannaz Jamialahmadi ,&nbsp;Ali H. Eid ,&nbsp;Kishore M. Gadde ,&nbsp;Wael Almahmeed ,&nbsp;Matthew Kroh ,&nbsp;Mohammad Al Zein ,&nbsp;Amirhossein Sahebkar","doi":"10.1016/j.clnu.2024.12.004","DOIUrl":"10.1016/j.clnu.2024.12.004","url":null,"abstract":"<div><div>This opinion paper aims to discuss the influence of semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1RA), on lean mass beyond its impact on weight loss. Although significant weight loss is achieved with semaglutide, the impact of this drug on lean mass remains controversial. Several investigations have demonstrated that semaglutide-induced weight loss is linked to decreases in lean mass as well as fat mass; on the other hand, the ratio of lean mass to total body mass rises. Nevertheless, larger clinical trials have reported converse findings and significant reductions in lean mass following treatment with semaglutide. This disparity in research findings emphasizes the necessity for additional studies on this subject because semaglutide use is rising quickly.</div></div>","PeriodicalId":10517,"journal":{"name":"Clinical nutrition","volume":"44 ","pages":"Pages 104-108"},"PeriodicalIF":6.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142794186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the Editor-Dairy consumption and risk of prediabetes and type 2 diabetes in the Fenland study 致编辑:芬兰研究中的乳制品消费与前驱糖尿病和2型糖尿病的风险
IF 6.6 2区 医学 Q1 NUTRITION & DIETETICS Pub Date : 2025-01-01 DOI: 10.1016/j.clnu.2024.12.009
Kun Zhao, Zhenliang Sun
{"title":"Letter to the Editor-Dairy consumption and risk of prediabetes and type 2 diabetes in the Fenland study","authors":"Kun Zhao,&nbsp;Zhenliang Sun","doi":"10.1016/j.clnu.2024.12.009","DOIUrl":"10.1016/j.clnu.2024.12.009","url":null,"abstract":"","PeriodicalId":10517,"journal":{"name":"Clinical nutrition","volume":"44 ","pages":"Pages 125-126"},"PeriodicalIF":6.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142812345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving standards of letters to the editor 提高给编辑的信件的标准。
IF 6.6 2区 医学 Q1 NUTRITION & DIETETICS Pub Date : 2025-01-01 DOI: 10.1016/j.clnu.2024.11.024
Carla M. Prado, Dileep N. Lobo, Nicolaas E.P. Deutz
{"title":"Improving standards of letters to the editor","authors":"Carla M. Prado,&nbsp;Dileep N. Lobo,&nbsp;Nicolaas E.P. Deutz","doi":"10.1016/j.clnu.2024.11.024","DOIUrl":"10.1016/j.clnu.2024.11.024","url":null,"abstract":"","PeriodicalId":10517,"journal":{"name":"Clinical nutrition","volume":"44 ","pages":"Pages 102-103"},"PeriodicalIF":6.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142791177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biomarkers of oxidation, inflammation and intestinal permeability in persons with diabetes mellitus with parenteral nutrition: A multicenter randomized trial 接受肠外营养的糖尿病患者体内氧化、炎症和肠道渗透性的生物标志物:一项多中心随机试验。
IF 6.6 2区 医学 Q1 NUTRITION & DIETETICS Pub Date : 2025-01-01 DOI: 10.1016/j.clnu.2024.11.044
Virginia Soria-Utrilla , Corina Verónica Sasso , Silvana Yanina Romero-Zerbo , Antonio Adarve-Castro , Rafael López-Urdiales , Sandra Herranz-Antolín , José Manuel García-Almeida , Katherine García-Malpartida , Mercedes Ferrer-Gómez , Alicia Moreno-Borreguero , Luis Miguel Luengo-Pérez , Julia Álvarez-Hernández , Carmen Aragón-Valera , María Julia Ocón-Bretón , Álvaro García-Manzanares , Irene Bretón-Lesmes , Pilar Serrano-Aguayo , Natalia Pérez-Ferre , Juan José López-Gómez , Josefina Olivares-Alcolea , Gabriel Olveira

Background and aims

Parenteral nutrition (PN) composition could play a role in the management of systemic inflammatory response and intestinal barrier disruption. We aimed to evaluate changes in biomarkers of inflammation, oxidative status and intestinal permeability in patients with type 2 diabetes mellitus (T2DM) who received different PN lipid formulas.

Methods

This was a prospective study, including 94 patients with T2DM who received omega (n)-3 polyunsaturated fatty acids (PUFA)-enriched PN, a mixture of medium and long chain triglycerides (MCT/LCT) PN, or an olive oil-based PN. Serum levels of biomarkers of oxidative status, intestinal permeability and inflammation biomarkers were determined at day 1 and day 5 after PN initiation. Registered under ClinicalTrials.gov Identifier no. NCT02706119.

Results

At day 5 after the onset of PN, the MCT/LCT group had a significant reduction of 2 proinflammatory cytokines [interleukin (IL)-15, IL-17A], elevation of the anti-inflammatory cytokine IL-13 and increase of zonulin and indoxylsulfate. The olive oil group showed a statistically significant reduction of 5 proinflammatory cytokines [IL-1β, IL-17A, IL-6, cytokine-leukemia inhibitory factor (LIF) and tumor necrosis factor alpha (TNF-α)] and reduced concentrations of the anti-inflammatory cytokine IL-1RA, while the n-3 PUFA-enriched group presented a statistically significant reduction of 8 proinflammatory cytokines (interferon-gamma, IL-1β, IL-15, IL-17A, IL-6, LIF, monocyte chemoattractant protein 1, and TNF-α). In the between-group comparisons, indoxylsulfate significantly increased in the MCT/LCT group compared to the n-3 PUFA-enriched group, while 8-isoprostane and indoxylsulfate significantly increased in the MCT/LCT group compared to the other groups and superoxide dismutase significantly decreased in the MCT/LCT group compared to the other groups.

Conclusion

In patients with T2DM, PN lipid composition exerts a profound impact on proinflammatory, prooxidative and intestinal permeability biomarkers.
背景和目的:肠外营养(PN)成分可能在全身性炎症反应和肠屏障破坏的管理中发挥作用。我们旨在评估接受不同PN脂质配方治疗的2型糖尿病(T2DM)患者炎症、氧化状态和肠通透性生物标志物的变化。方法:这是一项前瞻性研究,包括94例T2DM患者,他们接受了富含omega (n)-3多不饱和脂肪酸(PUFA)的PN,中长链甘油三酯(MCT/LCT)的混合物PN或橄榄油基PN。在PN启动后第1天和第5天测定血清氧化状态、肠通透性和炎症生物标志物水平。注册编号:ClinicalTrials.govNCT02706119。结果:在PN发病后第5天,MCT/LCT组2种促炎细胞因子[白细胞介素(IL)-15、IL- 17a]显著降低,抗炎细胞因子IL-13升高,zonulin和吲哚基硫酸盐升高。橄榄油组5种促炎因子[IL-1β、IL-17A、IL-6、细胞因子-白血病抑制因子(LIF)、肿瘤坏死因子α (TNF-α)]降低,抗炎因子IL-1RA浓度降低,而n-3 pufa富集组8种促炎因子(干扰素- γ、IL-1β、IL-15、IL-17A、IL-6、LIF、单核细胞趋化蛋白1、TNF-α)降低,具有统计学意义。在组间比较中,与n-3 pufa富集组相比,MCT/LCT组的吲哚基硫酸显著升高,MCT/LCT组的8-异前列腺素和吲哚基硫酸显著升高,MCT/LCT组的超氧化物歧化酶显著降低。结论:在T2DM患者中,PN脂质组成对促炎、促氧化和肠通透性生物标志物有深远影响。
{"title":"Biomarkers of oxidation, inflammation and intestinal permeability in persons with diabetes mellitus with parenteral nutrition: A multicenter randomized trial","authors":"Virginia Soria-Utrilla ,&nbsp;Corina Verónica Sasso ,&nbsp;Silvana Yanina Romero-Zerbo ,&nbsp;Antonio Adarve-Castro ,&nbsp;Rafael López-Urdiales ,&nbsp;Sandra Herranz-Antolín ,&nbsp;José Manuel García-Almeida ,&nbsp;Katherine García-Malpartida ,&nbsp;Mercedes Ferrer-Gómez ,&nbsp;Alicia Moreno-Borreguero ,&nbsp;Luis Miguel Luengo-Pérez ,&nbsp;Julia Álvarez-Hernández ,&nbsp;Carmen Aragón-Valera ,&nbsp;María Julia Ocón-Bretón ,&nbsp;Álvaro García-Manzanares ,&nbsp;Irene Bretón-Lesmes ,&nbsp;Pilar Serrano-Aguayo ,&nbsp;Natalia Pérez-Ferre ,&nbsp;Juan José López-Gómez ,&nbsp;Josefina Olivares-Alcolea ,&nbsp;Gabriel Olveira","doi":"10.1016/j.clnu.2024.11.044","DOIUrl":"10.1016/j.clnu.2024.11.044","url":null,"abstract":"<div><h3>Background and aims</h3><div>Parenteral nutrition (PN) composition could play a role in the management of systemic inflammatory response and intestinal barrier disruption. We aimed to evaluate changes in biomarkers of inflammation, oxidative status and intestinal permeability in patients with type 2 diabetes mellitus (T2DM) who received different PN lipid formulas.</div></div><div><h3>Methods</h3><div>This was a prospective study, including 94 patients with T2DM who received omega (n)-3 polyunsaturated fatty acids (PUFA)-enriched PN, a mixture of medium and long chain triglycerides (MCT/LCT) PN, or an olive oil-based PN. Serum levels of biomarkers of oxidative status, intestinal permeability and inflammation biomarkers were determined at day 1 and day 5 after PN initiation. Registered under <span><span>ClinicalTrials.gov</span><svg><path></path></svg></span> Identifier no. NCT02706119.</div></div><div><h3>Results</h3><div>At day 5 after the onset of PN, the MCT/LCT group had a significant reduction of 2 proinflammatory cytokines [interleukin (IL)-15, IL-17A], elevation of the anti-inflammatory cytokine IL-13 and increase of zonulin and indoxylsulfate. The olive oil group showed a statistically significant reduction of 5 proinflammatory cytokines [IL-1β, IL-17A, IL-6, cytokine-leukemia inhibitory factor (LIF) and tumor necrosis factor alpha (TNF-α)] and reduced concentrations of the anti-inflammatory cytokine IL-1RA, while the n-3 PUFA-enriched group presented a statistically significant reduction of 8 proinflammatory cytokines (interferon-gamma, IL-1β, IL-15, IL-17A, IL-6, LIF, monocyte chemoattractant protein 1, and TNF-α). In the between-group comparisons, indoxylsulfate significantly increased in the MCT/LCT group compared to the n-3 PUFA-enriched group, while 8-isoprostane and indoxylsulfate significantly increased in the MCT/LCT group compared to the other groups and superoxide dismutase significantly decreased in the MCT/LCT group compared to the other groups.</div></div><div><h3>Conclusion</h3><div>In patients with T2DM, PN lipid composition exerts a profound impact on proinflammatory, prooxidative and intestinal permeability biomarkers.</div></div>","PeriodicalId":10517,"journal":{"name":"Clinical nutrition","volume":"44 ","pages":"Pages 155-164"},"PeriodicalIF":6.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142821868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the editor “Quality of life of caregivers of patients on home enteral nutrition” 致编辑的信“家庭肠内营养患者护理人员的生活质量”。
IF 6.6 2区 医学 Q1 NUTRITION & DIETETICS Pub Date : 2025-01-01 DOI: 10.1016/j.clnu.2024.12.002
Júlio César de Carvalho Martins, Matheus Santos de Sousa Fernandes, Raphael Fabricio de Souza
{"title":"Letter to the editor “Quality of life of caregivers of patients on home enteral nutrition”","authors":"Júlio César de Carvalho Martins,&nbsp;Matheus Santos de Sousa Fernandes,&nbsp;Raphael Fabricio de Souza","doi":"10.1016/j.clnu.2024.12.002","DOIUrl":"10.1016/j.clnu.2024.12.002","url":null,"abstract":"","PeriodicalId":10517,"journal":{"name":"Clinical nutrition","volume":"44 ","pages":"Pages 220-221"},"PeriodicalIF":6.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142876627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the Editor: “ESPEN Guideline on Nutrition and Hydration in Dementia–Update 2024” 致编辑的信:“ESPEN指南关于痴呆症的营养和水合作用-更新2024”。
IF 6.6 2区 医学 Q1 NUTRITION & DIETETICS Pub Date : 2025-01-01 DOI: 10.1016/j.clnu.2024.11.013
Artur Barbosa Gomes, David de Sousa Cortez Barros, Nayara Rodrigues de Carvalho
{"title":"Letter to the Editor: “ESPEN Guideline on Nutrition and Hydration in Dementia–Update 2024”","authors":"Artur Barbosa Gomes,&nbsp;David de Sousa Cortez Barros,&nbsp;Nayara Rodrigues de Carvalho","doi":"10.1016/j.clnu.2024.11.013","DOIUrl":"10.1016/j.clnu.2024.11.013","url":null,"abstract":"","PeriodicalId":10517,"journal":{"name":"Clinical nutrition","volume":"44 ","pages":"Page 101"},"PeriodicalIF":6.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142791178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical nutrition
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1